What has changed
The federal Department of Health, Ageing and Disability has made the National Health (Listed Drugs on F1 or F2) Amendment Determination (No. 5) 2026. This instrument amends the National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021), which sets out the drugs listed on the Pharmaceutical Benefits Scheme (PBS) F1 and F2 formularies.
The amendment is made under the National Health Act 1953.
Key dates
- Commenced: 29 May 2026
- Repealed: 7 September 2026
What the source does not specify
The source summary does not specify which drugs were added, removed, or otherwise changed by this amendment. The full schedule of amendments to PB 33 of 2021 is available in the legislative instrument.
Key actions
- If you supply, dispense, or claim PBS-listed medicines, check the updated F1/F2 drug list effective 29 May 2026 at https://www.legislation.gov.au/F2026L00639 to confirm which drugs are covered.
- Note that this determination is repealed on 7 September 2026 - monitor for a replacement determination if you rely on F1/F2 listings for billing or stock decisions.
- View the full legislative instrument and explanatory statement at https://www.legislation.gov.au/F2026L00639 for the specific schedule of amendments to PB 33 of 2021.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.